• American Joint Committee on Cancer

Summary of Changes

Tumor staging (T) has been revised and the categories redefined.

T4 is now divided into T4a and T4b.

Nodal staging (N) has been revised.

All anaplastic carcinomas are considered T4. The T4 category for anaplastic carcinomas is divided into T4a (intrathyroidal anaplastic carcinoma—surgically resectable) and T4b (extrathyroidal anaplastic carcinoma—surgically unresectable).

For papillary and follicular carcinomas, the stage grouping for patients older than 45 has been revised. Stage III includes tumors with minimal extrathyroid extension. Stage IVA includes tumors of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus OR recurrent laryngeal nerve. Stage IVB includes tumors that invade prevertebral fascia, carotid artery, or mediastinal vessels. Stage IVC includes advanced tumors with distant metastasis. J


Thyroid Cancer Thyroid Gland Papillary Thyroid Carcinoma Papillary Carcinoma American Joint Committee 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ain KB: Papillary thyroid carcinoma: etiology, assessment, and therapy. Endocrinol Metab Clin North Am 24:711–760, 1995PubMedGoogle Scholar
  2. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP: Differentiated carcinoma of the thyroid with extrathyroid extension—risks for failure and patterns of recurrence. Am J Surg 170:467–470, 1995PubMedCrossRefGoogle Scholar
  3. Antonacci A, Brierley G, Bacchi F, Consorti C, et al: Thyroid cancer. In Hermanek P, Gospodarowicz MK, Henson DE, et al (Eds.): Prognostic factors in cancer. Berlin: Springer-Verlag 28–36, 1995CrossRefGoogle Scholar
  4. Brierley JD, Panzarella T, Tsang RW, et al: Comparing staging classifications using thyroid cancer as an example. Cancer 79:2414–2413, 1997PubMedCrossRefGoogle Scholar
  5. Brierley J, Tsang R, Simpson WJ, et al: Medullary thyroid cancer—analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310, 1996PubMedCrossRefGoogle Scholar
  6. Cady B, Rossi R, Silverman M, et al: Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 98:1171–1178, 1985PubMedGoogle Scholar
  7. Cohn K, Blackdahl M, Forsslund G, et al: Prognostic value of nuclear DNA content in papillary thyroid carcinoma. World J Surg 8:474–480, 1984PubMedCrossRefGoogle Scholar
  8. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088–1095, 1987PubMedGoogle Scholar
  9. Hedinger C. Histological typing of thyroid tumours: WHO international histological classification of tumours, 2nd ed. Berlin-Heidelberg-New York: Springer-Verlag, 1988CrossRefGoogle Scholar
  10. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee R, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S (United States and German Thyroid Cancer Study Group): Initial results from a prospective cohort of 5,583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89:202–217, 2000PubMedCrossRefGoogle Scholar
  11. LiVolsi VA. Surgical pathology of the thyroid. Philadelphia: WB Saunders, 1990Google Scholar
  12. Mazzaferri EL, Jhiang S: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428, 1994PubMedCrossRefGoogle Scholar
  13. McConahey WM, Hay ID, Woolner LB, et al: Papillary thyroid cancer treated at the Mayo Clinic 1946–1970: initial manifestations, pathological findings, therapy and outcome. Mayo Clinic Proc 61:978–996, 1986CrossRefGoogle Scholar
  14. Rosai J, Carcangiu L, DeLellis RA: Tumors of the thyroid gland, 3rd series. Washington, DC: Armed Forces Institute of Pathology, 1992Google Scholar
  15. Rossi R: Prognosis of undifferentiated carcinoma and lymphoma of the thyroid. Am J Surg 135:589–596, 1978PubMedCrossRefGoogle Scholar
  16. Saad MF, Ordonez NG, Rashid RK, et al: Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63:319–342, 1984PubMedCrossRefGoogle Scholar
  17. Shah JP, Loree TR, Dharker D, et al: Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1645:658–661, 1992CrossRefGoogle Scholar
  18. Shaha AR, Loree TR, Shah JP: Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131–1138, 1995PubMedCrossRefGoogle Scholar
  19. Shaha AR, Shah JP, Loree TR: Risk group stratification and prognostic factors in papillary carcinoma of the thyroid. Ann Surg Onc3:534–538, 1996Google Scholar
  20. Simpson WL, Panzarella T, Carruthers JS, et al: Papillary and follicular thyroid cancer: impact of treatment in 1,578 patients. Int J Radiation Oncol Biol Phys 14:1063–1075, 1988CrossRefGoogle Scholar
  21. Young RL, Mazzaferri EL, Rahea J, et al: Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 21:733–737, 1980PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations